0001453687-19-000111.txt : 20190816 0001453687-19-000111.hdr.sgml : 20190816 20190816161657 ACCESSION NUMBER: 0001453687-19-000111 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190125 FILED AS OF DATE: 20190816 DATE AS OF CHANGE: 20190816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farokhzad Omid CENTRAL INDEX KEY: 0001586852 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37798 FILM NUMBER: 191033669 MAIL ADDRESS: STREET 1: C/O BIND THERAPEUTICS, INC. STREET 2: 325 VASSAR ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SELECTA BIOSCIENCES INC CENTRAL INDEX KEY: 0001453687 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-923-1400 MAIL ADDRESS: STREET 1: 480 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 4/A 1 wf-form4a_156598660162280.xml FORM 4/A X0306 4/A 2019-01-25 2019-03-29 0 0001453687 SELECTA BIOSCIENCES INC SELB 0001586852 Farokhzad Omid C/O SELECTA BIOSCIENCES, INC. 480 ARSENAL WAY WATERTOWN MA 02472 1 0 0 0 Common Stock 25626 I See Footnote Common Stock 202051 I See Footnote Common Stock 188004 D These shares were omitted from the Reporting Person's original Form 4 filed on March 29, 2019. These securities are held by BioDynamics Core, L.P., which is managed by BioDynamics, LLC, of which the Reporting Person is a member. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These securities are held by SAF-SEL Trust, for which the Reporting Person's spouse serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. /s/ Matthew Bartholomae, Attorney-in-Fact for Omid Farokhzad 2019-08-16